Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
At the American Academy of Dermatology Annual Meeting, Eli Lilly And Co (NYSE:LLY) and Incyte Corp (NASDAQ:INCY) shared a 52-week analysis of Olumiant (baricitinib) in adults with severe alopecia areata, unpredictable, patchy hair loss.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Patients who took Olumiant achieved significant scalp, eyelash, and eyebrow hair regrowth, and nearly 75% of those who responded to Olumiant 4-mg achieved 90% scalp coverage at 52 weeks.
- In February, the FDA granted priority review for Olumiant in severe AA as a potential first-in-disease medicine.
- Lilly expects regulatory decisions in the U.S., European Union, and Japan in 2022.
- In the pooled 52-week analysis, two out of five patients who took Olumiant 4-mg (39.0%, n=201/515) achieved significant scalp hair regrowth, defined as 80% or more scalp hair coverage. Nearly three out of four patients (74.1%, n=149/201) achieved 90% hair coverage at 52 weeks.
- More than two out of five patients saw full regrowth or regrowth with minimal gaps in eyebrow and eyelash hair.
- Among patients who took Olumiant 2-mg, more than one out of five (22.6%, n=77/340) achieved significant scalp hair regrowth, and two out of three (67.5%, n=52/77) gained 90% or more hair coverage at 52 weeks.
- Price Action: INCY shares closed 0.35% higher at $78.46, and LLY stock closed at $289.02 on Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.